Gerald Commissiong
Fondatore presso AMARANTUS BIOSCIENCE HOLDINGS, INC.
Posizioni attive di Gerald Commissiong
Società | Posizione | Inizio | Fine |
---|---|---|---|
AMARANTUS BIOSCIENCE HOLDINGS, INC. | Presidente | 01/04/2021 | - |
Fondatore | 14/01/2008 | - | |
Contatto Relazioni con gli Investitori | 14/01/2008 | - | |
Presidente | 31/10/2011 | - | |
Direttore/Membro del Consiglio | 01/04/2011 | 01/04/2021 | |
Amministratore Delegato | 31/10/2011 | 31/03/2021 | |
Direttore operativo | 01/04/2011 | 03/05/2013 | |
Public Communications Contact | 14/01/2008 | 03/05/2013 | |
TODOS MEDICAL LTD. | Direttore/Membro del Consiglio | 05/01/2020 | - |
Amministratore Delegato | 05/01/2020 | - | |
Presidente | 05/01/2020 | - | |
Cutanogen Corp.
Cutanogen Corp. BiotechnologyHealth Technology Part of Gemini Strategies LLC, Inc., Cutanogen Corp. is a company that develops artificial skin products used to treat patients with severe burns. The company is based in Cincinnati, OH. The CEO of the company is Gerald E. Commissiong. Cutanogen was acquired by Amarantus Bioscience Holdings, Inc. from Lonza Group AG on July 15, 2015 for $9 million. | Amministratore Delegato | - | - |
Elto Pharma, Inc.
Elto Pharma, Inc. Pharmaceuticals: MajorHealth Technology Elto Pharma, Inc. develops Eltoprazine, an oral small molecule 5HT1A/1B partial agonist in clinical development for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID), aggression in Alzheimer's disease and adult attention deficit hyperactivity disorder (adult ADHD).The company was founded on April 12, 2017 and is headquartered in Nevada, the United States of America. | Direttore/Membro del Consiglio | - | - |
Presidente | - | - | |
Segretario Aziendale | - | - | |
Treasurer | - | - | |
Breakthrough Diagnostics, Inc.
Breakthrough Diagnostics, Inc. BiotechnologyHealth Technology Breakthrough Diagnostics, Inc. engages in the development of blood tests for the early detection of neurodegenerative disorders. Its primary product is the Lympro Test, a blood screening diagnostic test for Alzheimer’s disease. The company is headquartered in New York, NY. | Amministratore Delegato | - | - |
Provista Diagnostics, Inc.
Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Presidente | - | - |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01/04/2024 | - |
Storia della carriera di Gerald Commissiong
Precedenti posizioni note di Gerald Commissiong
Società | Posizione | Inizio | Fine |
---|---|---|---|
Jumpkicks, Inc.
Jumpkicks, Inc. Specialty StoresRetail Trade Jumpkicks, Inc. provides online retailing services. The company also provides content of interest to martial artists and selling products, such as uniforms, t-shirts, protective equipment, mats and other equipment and accessories. The company was founded on August 3, 2007 and is headquartered in Henderson, NV. | Direttore/Membro del Consiglio | 01/06/2011 | 08/06/2011 |
Direttore operativo | 01/06/2011 | 08/06/2011 | |
AVANT DIAGNOSTICS INC | Direttore/Membro del Consiglio | 14/05/2016 | - |
Formazione di Gerald Commissiong
Stanford University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Israele | 2 |
Posizioni
Director/Board Member | 5 |
Chief Executive Officer | 4 |
President | 4 |
Settori
Health Technology | 7 |
Commercial Services | 3 |
Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
AMARANTUS BIOSCIENCE HOLDINGS, INC. | Health Technology |
TODOS MEDICAL LTD. | Health Technology |
Commercial Services |
Aziende private | 6 |
---|---|
Jumpkicks, Inc.
Jumpkicks, Inc. Specialty StoresRetail Trade Jumpkicks, Inc. provides online retailing services. The company also provides content of interest to martial artists and selling products, such as uniforms, t-shirts, protective equipment, mats and other equipment and accessories. The company was founded on August 3, 2007 and is headquartered in Henderson, NV. | Retail Trade |
Theralink Technologies, Inc. (Colorado)
Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
Cutanogen Corp.
Cutanogen Corp. BiotechnologyHealth Technology Part of Gemini Strategies LLC, Inc., Cutanogen Corp. is a company that develops artificial skin products used to treat patients with severe burns. The company is based in Cincinnati, OH. The CEO of the company is Gerald E. Commissiong. Cutanogen was acquired by Amarantus Bioscience Holdings, Inc. from Lonza Group AG on July 15, 2015 for $9 million. | Health Technology |
Elto Pharma, Inc.
Elto Pharma, Inc. Pharmaceuticals: MajorHealth Technology Elto Pharma, Inc. develops Eltoprazine, an oral small molecule 5HT1A/1B partial agonist in clinical development for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID), aggression in Alzheimer's disease and adult attention deficit hyperactivity disorder (adult ADHD).The company was founded on April 12, 2017 and is headquartered in Nevada, the United States of America. | Health Technology |
Breakthrough Diagnostics, Inc.
Breakthrough Diagnostics, Inc. BiotechnologyHealth Technology Breakthrough Diagnostics, Inc. engages in the development of blood tests for the early detection of neurodegenerative disorders. Its primary product is the Lympro Test, a blood screening diagnostic test for Alzheimer’s disease. The company is headquartered in New York, NY. | Health Technology |
Provista Diagnostics, Inc.
Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Commercial Services |
- Borsa valori
- Insiders
- Gerald Commissiong
- Esperienza